Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Rating of "Buy"

Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are presently covering the company, MarketBeat.com reports. Five analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among […]

Related Keywords

United States , Raymond James , Davidp Rosenbaum , Redwood Wealth Management Group , Life Insurance Co , Cantor Fitzgerald , Citigroup , Ardelyx Inc , Hightower Advisors , Nasdaq , Willis Johnson Associates Inc , Get Free Report , Tower Advisors , Get Free , Ardelyx Daily , Ardelyx , Nasdaq Ardx , Cardx , Medical , Ratings , Consensus ,